NS
TGTX icon

NBC Securities’s TG Therapeutics TGTX Stock Holding History

NBC Securities’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6K Hold
521
– – ﹤0.01% 1510
2026
Q1 		$17.3K Hold
521
– – ﹤0.01% 1762
2025
Q4 		$15.5K Hold
521
– – ﹤0.01% 1871
2025
Q3 		$18.8K Sell
521
-2,503
-83% -$82.4K ﹤0.01% 1770
2025
Q2 		$108K Buy
3,024
+2,200
+267% +$81.9K 0.01% 1017
2025
Q1 		$32K Buy
824
+823
+82,300% +$27.7K ﹤0.01% 1307
2024
Q4 		$39 Sell
1
-1,308
-100% -$37.5K ﹤0.01% 1077
2024
Q3 		$30K Buy
1,309
+485
+59% +$10.6K ﹤0.01% 1349
2024
Q2 		$14K Hold
824
– – ﹤0.01% 1576
2024
Q1 		$12K Sell
824
-8,577
-91% -$137K ﹤0.01% 1640
2023
Q4 		$160K Buy
9,401
+2,409
+34% +$28K 0.02% 808
2023
Q3 		$58K Buy
+6,992
New +$97.5K 0.01% 1082

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

NBC Securities's TGTX Position: Q2 2026 in Review

NBC Securities held its TG Therapeutics (TGTX) position steady in Q2 2026 at 521 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

NBC Securities first reported a position in TGTX in Q3 2023 and has held it in 12 quarters since. The position peaked at $160K in Q4 2023. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • NBC Securities held 521 shares of TG Therapeutics worth $28.6K as of Q2 2026.
  • NBC Securities left its TG Therapeutics share count unchanged in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1510 holding.
  • NBC Securities first reported a position in TG Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's TG Therapeutics position peaked at $160K in Q4 2023.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.